Education
About Us
Working with TipRanks
Follow Us
Robert Flanagan Insider Profile
4 Followers
Robert Flanagan, Director at Sagent Pharm, holds 19.64K shares in W. P. Carey Inc. (Ticker: WPC), holds 9.25K shares in Sagent Pharm (Ticker: SGNT), holds 805.79K shares in Castle Brands (Ticker: ROX).
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
-2.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Robert Flanagan holds in companies
Most Profitable Insider Trade
Stock:
Sagent Pharm
(SGNT)
(SGNT)
Rating:Informative Sell
Date:Jul 02, 2014 - Jul 02, 2015
Return:+4.50%
The most profitable trade made by Robert Flanagan
Robert Flanagan's Trading History
Sagent Pharm
Feb 21, 2015
―
Uninformative Buy
―
$201.35K
W. P. Carey Inc.
Jul 02, 2025
Director
Uninformative Buy
―
$1.34M
Castle Brands
―
―
―
$1.02M
List of latest transactions for each holding click on a transaction to see Robert Flanagan's performance on stock
You May Also Like
Robert Flanagan insider profile FAQ
What is the percentage of profitable transactions made by Robert Flanagan?
The percentage of profitable transactions made by Robert Flanagan is 50%.
What is the average return per transaction made by Robert Flanagan?
The average return per transaction made by Robert Flanagan is -2.60%.
What stocks does Robert Flanagan hold?
Robert Flanagan holds: SGNT, WPC, ROX stocks.
What was Robert Flanagan’s latest transaction?
Robert Flanagan latest transaction was an Uninformative Buy of ―.
What was Robert Flanagan's most profitable transaction?
Robert Flanagan’s most profitable transaction was an Informative Sell of SGNT stock on July 2, 2014. The return on the trade was 4.50%.
What is Robert Flanagan's role in Sagent Pharm?
Robert Flanagan's role in Sagent Pharm is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.